102 related articles for article (PubMed ID: 18310534)
1. TGF-beta 1 and urinary excretion of pyridinium crosslinks: Two often overlooked risk factors for assessing risk of progression in patients with monoclonal gammopathy of undetermined significance.
Kapoor S
Haematologica; 2008 Mar; 93(3):e38. PubMed ID: 18310534
[No Abstract] [Full Text] [Related]
2. Diagnosis of multiple myeloma.
Kyle RA
Semin Oncol; 2002 Dec; 29(6 Suppl 17):2-4. PubMed ID: 12520477
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].
Scudla V; Budíková M; Petrová P; Minarík J; Pika T; Bacovský J; Adamová D; Langová K;
Klin Onkol; 2010; 23(3):171-81. PubMed ID: 20608327
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Rajkumar SV; Lacy MQ; Kyle RA
Blood Rev; 2007 Sep; 21(5):255-65. PubMed ID: 17367905
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
6. The search for meaning in monoclonal protein. Is it multiple myeloma or monoclonal gammopathy of undetermined significance?
Brigden ML
Postgrad Med; 1999 Aug; 106(2):135-42; quiz 185. PubMed ID: 10456045
[TBL] [Abstract][Full Text] [Related]
7. Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance: quantification by urinary pyridinium cross-links of collagen.
Pecherstorfer M; Seibel MJ; Woitge HW; Horn E; Schuster J; Neuda J; Sagaster P; Köhn H; Bayer P; Thiébaud D; Ludwig H
Blood; 1997 Nov; 90(9):3743-50. PubMed ID: 9345061
[TBL] [Abstract][Full Text] [Related]
8. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
Mayo MM; Johns GS
Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic criteria of multiple myeloma.
Kyle RA
Hematol Oncol Clin North Am; 1992 Apr; 6(2):347-58. PubMed ID: 1582977
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and different stages of multiple myeloma.
Scudla V; Petrova P; Minarik J; Pika T; Bacovsky J
Neoplasma; 2011; 58(6):499-506. PubMed ID: 21895403
[TBL] [Abstract][Full Text] [Related]
11. [Monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma].
Schleiffenbaum BE
Praxis (Bern 1994); 2012 Nov; 101(24):1521-9; quiz 1530-1. PubMed ID: 23184544
[No Abstract] [Full Text] [Related]
12. Bone remodelation markers are useful in the management of monoclonal gammopathies.
Hernández JM; Suquía B; Queizan JA; Fisac RM; Sanchez JJ; Fernández-Calvo FJ; García-Sanz R; Olivier C; Bárez A; Calmuntia MJ; García-Frade J; Portero JA; López R; Aguilera C; Navajo JA; San-Miguel JF
Hematol J; 2004; 5(6):480-8. PubMed ID: 15570289
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D and plasma cell dyscrasias: reviewing the significance.
Burwick N
Ann Hematol; 2017 Aug; 96(8):1271-1277. PubMed ID: 28502031
[TBL] [Abstract][Full Text] [Related]
14. [Management in paraproteinemia].
Sonneveld P; Löwenberg B
Ned Tijdschr Geneeskd; 1992 Feb; 136(8):384-5. PubMed ID: 1538819
[No Abstract] [Full Text] [Related]
15. [Contribution to the evaluation of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and in individual clinical stages of multiple myeloma].
Scudla V; Petrová P; Minarík J; Pika T; Budíková M; Bacovský J; Repovský S
Vnitr Lek; 2010 Jun; 56(6):591-601. PubMed ID: 20681472
[TBL] [Abstract][Full Text] [Related]
16. Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications.
Saeki Y; Mima T; Ishii T; Ogata A; Kobayashi H; Ohshima S; Ishida T; Tabunoki Y; Kitayama H; Mizuki M; Katada Y; Asaoku H; Kitano M; Nishimoto N; Yoshizaki K; Maeda M; Kon S; Kinoshita N; Uede T; Kawase I
Br J Haematol; 2003 Oct; 123(2):263-70. PubMed ID: 14531907
[TBL] [Abstract][Full Text] [Related]
17. A monoclonal gammopathy in search of clinical significance: 57 years later.
Go RS; Doyle LM
Blood; 2009 Sep; 114(11):2355-6; author reply 2356-7. PubMed ID: 19745077
[No Abstract] [Full Text] [Related]
18. [The comparison of serum levels of selected biomarkers in monoclonal gammopathy of undetermined significance and multiple myeloma].
Scudla V; Budíková M; Pika T; Bacovský J; Minarík J; Heinzová V; Langová K
Cas Lek Cesk; 2009; 148(7):315-22. PubMed ID: 19642297
[TBL] [Abstract][Full Text] [Related]
19. Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma.
Hayes MJ; Carey JL; Krauss JC; Hedstrom DL; Gulbranson RL; Keren DF
Eur J Haematol; 2007 Apr; 78(4):353-7. PubMed ID: 17378894
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal gammopathy of undetermined significance: new insights.
Chen BH
CMAJ; 2002 May; 166(10):1309. PubMed ID: 12041852
[No Abstract] [Full Text] [Related]
[Next] [New Search]
